Literature DB >> 15193956

Inhibition of the development of metastases by dietary vitamin C:K3 combination.

Henryk S Taper1, James M Jamison, Jacques Gilloteaux, Jack L Summers, Pedro Buc Calderon.   

Abstract

The tumor growth-inhibiting and chemo-potentiating effects of vitamin C and K(3)combinations have been demonstrated both in vitro and in vivo. The purpose of this study was to investigate the influence of orally administered vitamin C and K(3) on the metastasis of mouse liver tumor (T.L.T.) cells implanted in C3H mice. Adult male C3H mice were given water containing vitamin C and K3 (15 g/0.15 g dissolved in 1000 ml) beginning 2 weeks before tumor transplantation until the end of the experiment. T.L.T. cells (106) were implanted intramuscularly in the right thigh of mice. All mice were sacrificed 42 days after tumor transplantation. Primary tumor, lungs, lymph nodes and other organs or tissues suspected of harboring metastases were macroscopically examined. Samples of primary tumors, their local lymph nodes, lungs and main organs such as liver, kidneys, spleen were taken for histological examination. Forty-two percent of control mice exhibited lung metastases and 27% possessed metastases in local lymph nodes whereas 24% of vitamin-treated mice exhibited lung metastases and 10% possessed local lymph nodes metastases. The total number of lung metastases was 19 in control group and 10 in vitamin C and K(3)-treated mice. Histopathological examination of the metastatic tumors from the vitamin-treated mice revealed the presence of many tumor cells undergoing autoschizic cell death. These results demonstrate that oral vitamin C and K(3) significantly inhibited the metastases of T.L.T. tumors in C3H mice. At least a portion of this inhibition was due to tumor cell death by autoschizis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193956     DOI: 10.1016/j.lfs.2004.02.011

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy.

Authors:  Dean Lim; Robert J Morgan; Steven Akman; Kim Margolin; Brian I Carr; Lucille Leong; Oluwole Odujinrin; James H Doroshow
Journal:  Invest New Drugs       Date:  2005-06       Impact factor: 3.850

2.  Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.

Authors:  Tatyana V Masyuk; Brynn N Radtke; Angela J Stroope; Jesús M Banales; Anatoliy I Masyuk; Sergio A Gradilone; Gabriella Bedekovicsne Gajdos; Natasha Chandok; Jason L Bakeberg; Christopher J Ward; Erik L Ritman; Hiroaki Kiyokawa; Nicholas F LaRusso
Journal:  Gastroenterology       Date:  2011-12-07       Impact factor: 22.682

3.  Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.

Authors:  Brian I Carr; Siddhartha Kar; Meifang Wang; Ziqiu Wang
Journal:  Cell Biol Int       Date:  2007-03-19       Impact factor: 3.612

4.  The effect of carvacrol on healthy neurons and N2a cancer cells: some biochemical, anticancerogenicity and genotoxicity studies.

Authors:  Elanur Aydın; Hasan Türkez; M Sait Keleş
Journal:  Cytotechnology       Date:  2013-04-04       Impact factor: 2.058

5.  GC-FID and HPLC-DAD Methods for the Determination of Menadione Sodium Bisulphite Directly and by Converting Menadione Sodium Bisulphite to Menadione in Pharmaceutical Preparation.

Authors:  Fatma Demirkaya-Miloglu; Yucel Kadioglu; Onur Senol
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 6.  Current limitations of murine models in oncology for ascorbate research.

Authors:  Elizabeth J Campbell; Gabi U Dachs
Journal:  Front Oncol       Date:  2014-10-14       Impact factor: 6.244

7.  Proteomic analysis of tumor tissue in CT-26 implanted BALB/C mouse after treatment with ascorbic acid.

Authors:  Jihye Lee; Gunsup Lee; Jin Hee Park; Sukchan Lee; Chang-Hwan Yeom; Byungjo Na; Seyeon Park
Journal:  Cell Mol Biol Lett       Date:  2011-12-02       Impact factor: 5.787

Review 8.  Nanocarrier-mediated antioxidant delivery for liver diseases.

Authors:  Senlin Li; Huiru Li; Xiaoding Xu; Phei Er Saw; Lei Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

9.  Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.

Authors:  Rumiana Bakalova; Severina Semkova; Donika Ivanova; Zhivko Zhelev; Thomas Miller; Tsuguhide Takeshima; Sayaka Shibata; Dessislava Lazarova; Ichio Aoki; Tatsuya Higashi
Journal:  Oxid Med Cell Longev       Date:  2020-11-02       Impact factor: 6.543

10.  2-Bromo-1,4-naphthoquinone: a potentially improved substitute of menadione in Apatone™ therapy.

Authors:  F S Graciani; V F Ximenes
Journal:  Braz J Med Biol Res       Date:  2012-05-17       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.